Search Page
Save citations to file
Email citations
Email address has not been verified. Go to
My NCBI account settings
to confirm your email and then refresh this page.
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2017 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.
N Engl J Med. 2017 Dec 7;377(23):2215-2227. doi: 10.1056/NEJMoa1708538.
N Engl J Med. 2017.
PMID: 29211678
Free PMC article.
Clinical Trial.
Field Study and Correlative Studies of Factor IX Variant FIX-R338L in Participants Treated with Fidanacogene Elaparvovec.
Pittman DD, Carrieri C, Soares H, McKay J, Tan CY, Liang JZ, Rakhe S, Marshall JC, Murphy JE, Gaitonde P, Rupon J.
Pittman DD, et al.
Thromb Haemost. 2024 Oct;124(10):912-921. doi: 10.1055/s-0044-1787734. Epub 2024 Jun 11.
Thromb Haemost. 2024.
PMID: 38863155
Free PMC article.
Clinical Trial.
Item in Clipboard
Population Modeling of Factor IX Activity Following Administration of Fidanacogene Elaparvovec Gene Therapy in Participants with Hemophilia B.
Wojciechowski J, Gaitonde P, Hughes JH, Ravva P.
Wojciechowski J, et al.
Clin Pharmacokinet. 2025 Oct;64(10):1531-1548. doi: 10.1007/s40262-025-01535-y. Epub 2025 Aug 1.
Clin Pharmacokinet. 2025.
PMID: 40750723
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.